Patents offer the economic guarantees scientists and companies need to develop new treatments, Oliver Bruestle told Deutsche Welle. He’s at the center of a German court battle surrounding embryonic stem cell research
Oliver Bruestle, director of the Institute of Reconstructive Neurobiology at the University of Bonn, is pushing for Germany to recognize the right to patent procedures conducted on embryonic stem cells, saying patents are the right way to ensure that scientists and companies profit from their work.
Greenpeace, however, is opposed to the patents. The organization filed suit against a patent granted to Bruestle in 1999, saying that the patenting
Cells grown in culture are not alone: They are constantly communicating with one another by sending signals through their culture media that are picked up and transmitted by other cells in the media. When thousands of cells are cultured together in a dish, there are hundreds of thousands of these signals present every minute, all competing to be heard.
Scientists trying to direct cells to do useful things — like causing stem cells to turn into neurons or heart cells — typically try to overcome these signals by adding their own exogenous factors. These exogenous factors are often added at
International Stem Cell Corporation, a California-based biotechnology company, today announced that the United States Patent and Trademark Office (USPTO) has granted the Company a patent for a method of creating pure populations of definitive endoderm, precursor cells to liver and pancreas cells, from human pluripotent stem cells. This patent is a key element of ISCO’s metabolic liver disease program and allows the Company to produce the necessary quantities of precursor cells in a more efficient and cost effective manner.
The patent, 8,268,621, adds to the Company’s growing portfolio of proprietary technologies relating to the development of potential treatments
Stem Cell Research Clinical Study- Spinal Cord Injury
A few weeks ago, I covered a story about a stem cell research published study for spinal cord injury patients in Ecuador. In that study, Dr. Luis Geffner used 3 different delivery methods of Adult Stem Cells to help 52 spinal cord injury patients and counting.
Michael Flounders- Walking […]
Image by cap21photo via Flickr
On May 6, France’s Council of State (the highest administrative court and legal advisor to the executive branch) declared that it was against the practice of “renting out one’s uterus” and in favor of the permanent authorization regulations for embryo research and embryonic stem cell research under certain conditions. French Prime Minister Francois Fillon had asked the court for its opinion, in a reexamination of a 2004 bioethics law.
-Considering the interest of the child and the mother carrying the child and basic underlying principles of the present ban, we hereby recommend to not legalize